P. Frei

Anti-pre-S2 antibody response in subjects vaccinated against hepatitis B and in naturally immunized subjects.

D. Lavanchy, B. Fritzell, B. Geudelin, 1991, Research in virology.

Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?

C. Mayerat, A. Mantegani, P. Frei, 1999, Journal of viral hepatitis.

Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery.

D. Lavanchy, P. Zuber, P. Jacquier, 2008, Liver.

Seroprevalence of hepatitis E virus in Switzerland

D. Lavanchy, B. Morel, P. Frei, 1994, The Lancet.

Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/ hepatitis B vaccination in 242 adult volunteers

P. Francioli, A. Safary, P. Frei, 1998, Journal of viral hepatitis.

Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.

P. Bovet, D. Lavanchy, C. Yersin, 1999, Bulletin of the World Health Organization.

Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen

D. Lavanchy, J. Gonvers, A. Pécoud, 1994, Journal of clinical microbiology.

Immunogenicity of a recombinant pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster

P. Francioli, D. Lavanchy, B. Fritzell, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Evaluation of a new automated third‐generation anti‐HCV enzyme immunoassay

D. Lavanchy, J. Steinmann, P. Frei, 1996, Journal of clinical laboratory analysis.